Joby Aviation (JOBY) 10-Q 4 Nov 22 2022 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2022	Nov. 02, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-39524
Entity Registrant Name	Joby Aviation, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	98-1548118
Entity Address, Address Line One	2155 Delaware Avenue
Entity Address, Address Line Two	Suite #225
Entity Address, City or Town	Santa Cruz
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95060
City Area Code	831
Local Phone Number	201-6700
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		621,731,378
Entity Central Index Key	0001819848
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3
Amendment Flag	false
Common Stock
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001
Trading Symbol	JOBY
Security Exchange Name	NYSE
Common stock warrants
Document Information [Line Items]
Title of 12(b) Security	Warrants to purchase common stock
Trading Symbol	JOBY WS
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 193,844	$ 955,563
Short-term investments	880,662	343,248
Total cash, cash equivalents and short-term investments	1,074,506	1,298,811
Restricted cash	3,204	0
Other receivables	6,092	2,315
Prepaid expenses and other current assets	20,234	17,416
Total current assets	1,104,036	1,318,542
Property and equipment, net	62,954	53,155
Restricted cash	762	762
Equity method investment	12,486	20,306
Intangible assets	14,198	14,512
Goodwill	14,011	10,757
Other non-current assets	65,362	70,321
Total assets	1,273,809	1,488,355
Current liabilities
Accounts payable	4,302	3,637
Accrued and other current liabilities	24,500	10,211
Total current liabilities	28,802	13,848
Stock repurchase liability	463	711
Warrant liability	24,175	44,902
Earnout shares liability	58,499	109,844
Other non-current liabilities	1,715	2,291
Total liabilities	113,654	171,596
Commitments and contingencies (Note 7)
Stockholders’ equity:
Preferred stock: $0.0001 par value - 100,000,000 shares authorized at September 30, 2022 and December 31, 2021. No shares issued and outstanding at September 30, 2022 and December 31, 2021.	0	0
Common stock: $0.0001 par value - 1,400,000,000 and 1,400,000,000 shares authorized, 609,566,379 and 604,174,329 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively.	60	60
Additional paid-in capital	1,837,332	1,793,431
Accumulated deficit	(667,709)	(476,610)
Accumulated other comprehensive loss	(9,528)	(122)
Total stockholders’ equity	1,160,155	1,316,759
Total liabilities and stockholders’ equity	$ 1,273,809	$ 1,488,355

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock , par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred stock shares authorized (in shares)	100,000,000	100,000,000
Preferred stock shares outstanding (in shares)	0	0
Preferred stock, shares Issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,400,000,000	1,400,000,000
Common stock, shares, issued (in shares)	609,566,379	604,174,329
Common stock, shares outstanding (in shares)	609,566,379	604,174,329

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses:
Research and development (including related party purchases of $243 and $547 for the three months ended September 30, 2022 and 2021, respectively, $1,470 and $1,523 for the nine months ended September 30, 2022 and 2021, respectively.)	$ 73,870	$ 52,092	$ 220,146	$ 140,310
Selling, general and administrative (including related party purchases of $46 and $154 for the three months ended September 30, 2022 and 2021, respectively, $335 and $390 for the nine months ended September 30, 2022 and 2021, respectively.)	23,251	15,607	70,700	41,587
Total operating expenses	97,121	67,699	290,846	181,897
Loss from operations	(97,121)	(67,699)	(290,846)	(181,897)
Interest and other income, net	5,395	163	8,766	872
Interest expense	(35)	(484)	(95)	(2,388)
Income from equity method investment	0	10,331	19,039	19,222
Transaction expenses related to merger	0	(9,015)	0	(9,015)
Gain (Loss) from change in fair value of warrants and earnout shares	12,560	(11,489)	72,072	(11,489)
Convertible notes extinguishment loss	0	(665)	0	(665)
Total other income (loss), net	17,920	(11,159)	99,782	(3,463)
Loss before income taxes	(79,201)	(78,858)	(191,064)	(185,360)
Income tax expense	5	0	35	9
Net loss	$ (79,206)	$ (78,858)	$ (191,099)	$ (185,369)
Net loss per share, basic (in dollars per share)	$ (0.14)	$ (0.20)	$ (0.33)	$ (0.91)
Net loss per share, diluted (in dollars per share)	$ (0.14)	$ (0.20)	$ (0.33)	$ (0.91)
Weighted average number of shares outstanding, basic (in shares)	583,970,409	385,560,732	581,458,391	203,536,351
Weighted average number of shares outstanding, diluted (in shares)	583,970,409	385,560,732	581,458,391	203,536,351

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Research and development, related party purchases	$ 243	$ 547	$ 1,470	$ 1,523
Selling, general and administrative, related party purchases	$ 46	$ 154	$ 335	$ 390

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Statement of Comprehensive Income [Abstract]
Net loss	$ (79,206)	$ (78,858)	$ (191,099)	$ (185,369)
Other comprehensive (loss) gain:
Unrealized loss on available-for-sale securities	(4,427)	(14)	(9,313)	(337)
Foreign currency translation gain (loss)	29	(94)	(93)	(42)
Total other comprehensive loss	(4,398)	(108)	(9,406)	(379)
Comprehensive loss	$ (83,604)	$ (78,966)	$ (200,505)	$ (185,748)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Preferred stock, beginning balance (in shares) at Dec. 31, 2020		332,764,215
Beginning balance at Dec. 31, 2020	$ (283,168)	$ 768,312	$ 12	$ 12,579	$ (296,286)	$ 527
Common stock, beginning balance (in shares) at Dec. 31, 2020			122,058,940
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(41,505)				(41,505)
Issuance of redeemable convertible preferred stock (in shares)		8,924,010
Issuance of redeemable convertible preferred stock		$ 77,619
Stock-based compensation	4,808			4,808
Other non-cash compensation expense	1,741			1,741
Issuance of common stock upon exercise of stock options (in shares)			746,830
Issuance of common stock upon exercise of stock options	303			303
Vesting of early exercised stock options	75			75
Other comprehensive loss	(309)					(309)
Preferred stock, ending balance (in shares) at Mar. 31, 2021		341,688,225
Common stock, ending balance (in shares) at Mar. 31, 2021			122,805,770
Ending balance at Mar. 31, 2021	(318,055)	$ 845,931	$ 12	19,506	(337,791)	218
Preferred stock, beginning balance (in shares) at Dec. 31, 2020		332,764,215
Beginning balance at Dec. 31, 2020	(283,168)	$ 768,312	$ 12	12,579	(296,286)	527
Common stock, beginning balance (in shares) at Dec. 31, 2020			122,058,940
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(185,369)
Preferred stock, ending balance (in shares) at Sep. 30, 2021		0
Common stock, ending balance (in shares) at Sep. 30, 2021			604,335,426
Ending balance at Sep. 30, 2021	1,304,671	$ 0	$ 60	1,786,118	(481,655)	148
Preferred stock, beginning balance (in shares) at Mar. 31, 2021		341,688,225
Beginning balance at Mar. 31, 2021	(318,055)	$ 845,931	$ 12	19,506	(337,791)	218
Common stock, beginning balance (in shares) at Mar. 31, 2021			122,805,770
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(65,006)				(65,006)
Issuance of redeemable convertible preferred stock (in shares)		2,677,200
Stock-based compensation	6,992			6,992
Other non-cash compensation expense	2,006			2,006
Issuance of common stock upon exercise of stock options (in shares)			592,948
Issuance of common stock upon exercise of stock options	217			217
Vesting of early exercised stock options	112			112
Other comprehensive loss	38					38
Preferred stock, ending balance (in shares) at Jun. 30, 2021		344,365,425
Common stock, ending balance (in shares) at Jun. 30, 2021			123,398,718
Ending balance at Jun. 30, 2021	(373,696)	$ 845,931	$ 12	28,833	(402,797)	256
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(78,858)				(78,858)
Stock-based compensation	7,618			7,618
Other non-cash compensation expense	2,028			2,028
Issuance of common stock upon exercise of stock options (in shares)			699,852
Issuance of common stock upon exercise of stock options	347			347
Issuance of common stock upon exercise of SVB warrants (in shares)			752,732
Vesting of early exercised stock options	50			50
Issuance of redeemable convertible preferred stock upon conversion exercise of In-Q-Tel warrants (in shares)		68,629
Issuance of redeemable convertible preferred stock upon conversion exercise of In-Q-Tel warrants	691			691
Issuance of common stock upon conversion of Uber convertible notes (in shares)			7,716,780
Issuance of common stock upon conversion of Uber convertible notes	77,399		$ 1	77,398
Conversion of redeemable convertible preferred stock upon reverse recapitalization (in shares)		344,434,054	344,434,054
Conversion of redeemable convertible preferred stock upon reverse recapitalization	845,931	$ (845,931)	$ 34	845,897
Issuance of common stock upon the reverse recapitalization, net of issuance costs (in shares)			127,333,290
Issuance of common stock upon reverse recapitalization, net of issuance costs	823,269		$ 13	823,256
Other comprehensive loss	(108)					(108)
Preferred stock, ending balance (in shares) at Sep. 30, 2021		0
Common stock, ending balance (in shares) at Sep. 30, 2021			604,335,426
Ending balance at Sep. 30, 2021	$ 1,304,671	$ 0	$ 60	1,786,118	(481,655)	148
Preferred stock, beginning balance (in shares) at Dec. 31, 2021	0	0
Beginning balance at Dec. 31, 2021	$ 1,316,759	$ 0	$ 60	1,793,431	(476,610)	(122)
Common stock, beginning balance (in shares) at Dec. 31, 2021	604,174,329		604,174,329
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (62,319)				(62,319)
Stock-based compensation	12,088			12,088
Issuance of common stock upon exercise of stock options (in shares)			823,524
Issuance of common stock upon exercise of stock options	428			428
Issuance of common stock upon release of restricted stock units (in shares)			851,557
Vesting of early exercised stock options	121			121
Stock withheld related to net share settlement (in shares)			(13,041)
Shares withheld related to net share settlement	(85)			(85)
Other comprehensive loss	(2,558)					(2,558)
Preferred stock, ending balance (in shares) at Mar. 31, 2022		0
Common stock, ending balance (in shares) at Mar. 31, 2022			605,836,369
Ending balance at Mar. 31, 2022	$ 1,264,434	$ 0	$ 60	1,805,983	(538,929)	(2,680)
Preferred stock, beginning balance (in shares) at Dec. 31, 2021	0	0
Beginning balance at Dec. 31, 2021	$ 1,316,759	$ 0	$ 60	1,793,431	(476,610)	(122)
Common stock, beginning balance (in shares) at Dec. 31, 2021	604,174,329		604,174,329
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (191,099)
Preferred stock, ending balance (in shares) at Sep. 30, 2022	0	0
Common stock, ending balance (in shares) at Sep. 30, 2022	609,566,379		609,566,379
Ending balance at Sep. 30, 2022	$ 1,160,155	$ 0	$ 60	1,837,332	(667,709)	(9,528)
Preferred stock, beginning balance (in shares) at Mar. 31, 2022		0
Beginning balance at Mar. 31, 2022	1,264,434	$ 0	$ 60	1,805,983	(538,929)	(2,680)
Common stock, beginning balance (in shares) at Mar. 31, 2022			605,836,369
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(49,574)				(49,574)
Stock-based compensation	15,869			15,869
Issuance of common stock upon exercise of stock options (in shares)			559,552
Issuance of common stock upon exercise of stock options	318			318
Issuance of common stock upon release of restricted stock units (in shares)			792,523
Vesting of early exercised stock options	65			65
Other comprehensive loss	(2,450)					(2,450)
Preferred stock, ending balance (in shares) at Jun. 30, 2022		0
Common stock, ending balance (in shares) at Jun. 30, 2022			607,188,444
Ending balance at Jun. 30, 2022	1,228,662	$ 0	$ 60	1,822,235	(588,503)	(5,130)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(79,206)				(79,206)
Stock-based compensation	14,673			14,673
Issuance of common stock upon exercise of stock options (in shares)			486,797
Issuance of common stock upon exercise of stock options	364			364
Issuance of common stock upon release of restricted stock units (in shares)			1,891,138
Vesting of early exercised stock options	60			60
Other comprehensive loss	$ (4,398)					(4,398)
Preferred stock, ending balance (in shares) at Sep. 30, 2022	0	0
Common stock, ending balance (in shares) at Sep. 30, 2022	609,566,379		609,566,379
Ending balance at Sep. 30, 2022	$ 1,160,155	$ 0	$ 60	$ 1,837,332	$ (667,709)	$ (9,528)

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net loss	$ (191,099)	$ (185,369)
Reconciliation of net loss to net cash used in operating activities:
Depreciation and amortization expense	17,422	11,467
Non-cash interest expense and amortization of debt costs	0	2,892
Stock-based compensation expense	51,905	19,418
Write-off of in-process research and development project	0	5,030
Other non-cash compensation expense	0	5,775
Loss from transaction costs related to merger	0	9,015
(Gain)/loss from change in the fair value of warrants and earnout shares	(72,072)	11,578
Income from equity method investment	(19,039)	(9,187)
Net accretion and amortization of investments in marketable debt securities	(874)	3,893
Changes in operating assets and liabilities
Other receivables and prepaid expenses and other current assets	(2,924)	(11,227)
Other non-current assets	31,852	(9,856)
Accounts payable and accrued and other liabilities	2,011	(435)
Net cash used in operating activities	(182,818)	(147,006)
Cash flows from investing activities
Purchase of marketable securities	(1,221,114)	(336,914)
Proceeds from sales of marketable securities	60,527	47,139
Proceeds from maturities of marketable securities	614,734	308,141
Purchases of property and equipment	(24,412)	(20,694)
Acquisition, net of cash	(5,707)	(4,981)
Net cash used in investing activities	(575,972)	(7,309)
Cash flows from financing activities
Taxes paid related to net share settlement of equity awards	(85)	0
Proceeds from merger	0	1,067,922
Proceeds from issuance of convertible notes	0	74,972
Proceeds from the exercise of stock options and warrants issuance	1,166	1,179
Repayments of tenant improvement loan and capital lease obligation	(806)	(813)
Payments for offering costs	0	(49,717)
Net cash provided by financing activities	275	1,093,543
Net change in cash, cash equivalents and restricted cash	(758,515)	939,228
Cash, cash equivalents and restricted cash, at the beginning of the period	956,325	78,030
Cash, cash equivalents and restricted cash, at the end of the period	197,810	1,017,258
Reconciliation of cash, cash equivalents and restricted cash to balance sheets
Cash and cash equivalents	193,844	1,016,496
Restricted cash	3,966	762
Cash, cash equivalents and restricted cash	197,810	1,017,258
Non-cash investing and financing activities
Unpaid property and equipment purchases	1,484	621
Uber Elevate acquisition in exchange for Series C redeemable convertible preferred stock	0	77,619
Property and equipment purchased through capital leases	252	926
Conversion of Uber note payable to Series C preferred stock	0	77,399
Unpaid offering costs	0	470
Conversion of preferred stock	0	846,622
Net non-cash assets acquired in merger	$ 0	$ 1,119

Company and Nature of Business

Company and Nature of Business	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Company and Nature of Business	Company and Nature of Business Description of Business Joby Aviation, Inc. (“Joby Aviation” or the “Company”) is a vertically integrated air mobility company that is building a clean, quiet, fully-electric vertical takeoff and landing (“eVTOL”) aircraft to be used by the Company to deliver air transportation as a service. The Company is headquartered in Santa Cruz, California. Merger with RTP On August 10, 2021 (the “Closing Date”), Reinvent Technology Partners, a Cayman Islands exempted company and special purpose acquisition company (“RTP”), completed the transactions contemplated by that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of February 23, 2021, by and among RTP, RTP Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of RTP (“RTP Merger Sub”), and Joby Aero, Inc., a Delaware corporation (“Legacy Joby”). On the Closing Date, RTP was domesticated as a Delaware corporation, Merger Sub merged with and into Legacy Joby and the separate corporate existence of Merger Sub ceased (the “Merger”), and Legacy Joby survived as a wholly-owned subsidiary of RTP, which changed its name to Joby Aviation, Inc. In connection with the execution of the Merger Agreement, RTP entered into separate subscription agreements (each a “Subscription Agreement”) with a number of investors (each a “PIPE Investor”), pursuant to which the PIPE Investors agreed to purchase, and RTP agreed to sell to the PIPE Investors, shares of Common Stock (“PIPE Shares”), in a private placement (“PIPE Financing”). The PIPE Financing closed substantially concurrently with the consummation of the Merger.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The condensed consolidated financial statements are unaudited and have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include all adjustments necessary for the fair presentation of the Company’s financial position as of September 30, 2022 and December 31, 2021 and results of operations for the three and nine months ended September 30, 2022 and 2021 and cash flows for the nine months ended September 30, 2022. The condensed consolidated financial statements include accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. There have been no changes to the Company’s significant accounting policies described in Note 2 “Summary of Significant Accounting Policies” to the audited Consolidated Financial Statements in the Company’s annual report on Form 10-K for the year ended December 31, 2021, that have had a material impact on the condensed consolidated financial statements and related notes. Certain information and footnote disclosures normally included in the Company’s annual audited Consolidated Financial Statements and accompanying notes have been condensed or omitted in these accompanying interim condensed consolidated financial statements and footnotes. Accordingly, the accompanying interim Condensed Consolidated Financial Statements included herein should be read in conjunction with the audited Consolidated Financial Statements and accompanying notes included in the Company’s annual report on Form 10-K for the year ended December 31, 2021. The results of operations presented in this quarterly report on Form 10-Q are not necessarily indicative of the results of operations to be expected for the year ending December 31, 2022, any other interim periods, or any future year or period. In the opinion of management, these unaudited Condensed Consolidated Financial Statements include all adjustments and accruals, consisting only of normal, recurring adjustments that are necessary for a fair statement of the results of all interim periods reported herein. Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments with remaining original maturity of three months or less, from the date of purchase, to be cash and cash equivalents. The recorded carrying amount of cash and cash equivalents approximates their fair value. At September 30, 2022, restricted cash primarily related to (i) approximately $2.2 million of cash temporarily retained by the Company to satisfy the Company’s post-closing indemnification claims, if any, against the seller, in connection with the acquisition of aerospace software engineering company in May 2022 (Note 4), (ii) a collateral on a letter of credit associated with key equipment purchases of approximately $1.0 million, and (iii) a security deposit for a lease obligation of approximately $0.8 million. At December 31, 2021, restricted cash primarily related to a security deposit for a lease obligation of approximately $0.8 million. Investment in SummerBio, LLC Following the outbreak of the COVID-19 pandemic, the Company’s management determined that certain previously developed technology that was accessible to the Company could be repurposed and applied in providing high-volume rapid COVID-19 testing through its investment in SummerBio, LLC (“SummerBio”), a related party. The Company has determined that it is not the primary beneficiary of SummerBio. Therefore, it accounts for its investment in SummerBio under the equity method of accounting with an ownership interest of approximately 43.4% as of September 30, 2022 and December 31, 2021. In June 2022, SummerBio notified the Company of its decision to wind down testing operations and close the business. As a result, the Company recorded an impairment loss on the Company’s investment of $6.8 million which is included within the income from equity method investment line on the condensed consolidated statement of operations and on the condensed consolidated statement of cash flow. The Company recognized income of nil and $10.3 million for the three months ended September 30, 2022 and 2021, respectively and income of $19.0 million (net of impairment loss) and $19.2 million for the nine months ended September 30, 2022 and 2021, respectively, within income from equity method investment on the condensed consolidated statement of operations for its investment in SummerBio. Recently Adopted Accounting Pronouncements In January 2020, the FASB issued ASU 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815): Clarifying the Interactions Between Topic 321, Topic 323, and Topic 815 - a consensus of the FASB Emerging Issues Task Force , which makes improvements related to the following two topics: (1) accounting for certain equity securities when the equity method of accounting is applied or discontinued, and (2) scope considerations related to forward contracts and purchased options on certain securities. The Company adopted this pronouncement in the first quarter of 2022 and the impact of the provisions of this standard on its Condensed Consolidated Financial Statements was immaterial. New Accounting Pronouncements Not Yet Adopted The Company is an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012. As such the Company is eligible for exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies, including reduced reporting and extended transition periods to comply with new or revised accounting standards for public business entities. The Company has elected to avail itself of this exemption and, therefore, will not be subject to the timeline for adopting new or revised accounting standards for public business entities that are not emerging growth companies, and will follow the transition guidance applicable to private companies. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) . In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842, Leases , which provides clarification to ASU No. 2016-02. These ASUs require an entity to recognize a lease liability and a right-of-use (“ROU”) asset in the balance sheets for leases with lease terms of more than 12 months. Lessor accounting is largely unchanged, while lessees will no longer be provided with a source of off-balance-sheet financing. This guidance is effective for fiscal years beginning after December 15, 2021, and for interim periods within fiscal years beginning after December 15, 2022. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements , which allows entities to elect a modified retrospective transition method where entities may continue to apply the existing lease guidance during the comparative periods and apply the new lease requirements through a cumulative effect adjustment in the period of adoptions rather than in the earliest period presented. The Company is currently evaluating, but has not yet completed, the assessment of the quantitative impact that adopting these ASUs will have on its consolidated financial statements and assessing any changes to its processes and controls. The Company currently estimates an ROU asset and lease liability of approximately $20 million to $30 million. These values are preliminary as the Company finalizes its review of lease agreements, incremental borrowing rates, and continues to evaluate material contracts for additional embedded lease agreements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. The guidance is effective for the Company beginning in the first quarter of 2023. The Company is evaluating the impact of adopting this guidance on its consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , that simplifies the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation and modified the methodology for calculating income taxes in an interim period. It also clarifies and simplifies other aspects of the accounting for income taxes. The guidance is effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022 with early adoption permitted. The Company is evaluating the effect of this guidance on its consolidated financial statements. In June 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Assets and liabilities recorded at fair value on a recurring basis in the condensed consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value represents the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows: • Level 1 - Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; • Level 2 - Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and • Level 3 - Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data. A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability. The Company’s financial assets consist of Level 1 and 2 assets. The Company classifies its cash equivalents and marketable debt securities within Level 1 or Level 2 because they are valued using either quoted market prices or inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. The Company’s fixed income available-for-sale securities consist of high quality, investment grade securities from diverse issuers. The valuation techniques used to measure the fair value of the Company’s marketable debt securities were derived from non-binding market consensus prices that are corroborated by observable market data and quoted market prices for similar instruments. The Company’s financial liabilities measured at fair value on a recurring basis consist of Level 1, Level 2 and Level 3 liabilities. The Company’s Public Warrants (as defined in Note 8) are classified as Level 1 because they are directly observable in the market. The Company classifies the Private Placement Warrants (as defined in Note 8) within Level 2, because they were valued using inputs other than quoted prices which are directly observable in the market, including readily available pricing for the Company’s Public Warrants. The Company classifies the Earnout Shares Liability (as defined in Note 8) within Level 3. The Earnout Shares Liability is measured at fair value on a recurring basis. Changes in fair value of Level 3 liabilities are recorded in other income, net, in the condensed consolidated statements of operations. The following tables set forth the fair value of the Company’s financial assets and liabilities measured on a recurring basis by level within the fair value hierarchy as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 Level 1 Level 2 Level 3 Total Assets measured at fair value Money market funds $ 166,438 $ — $ — $ 166,438 Cash equivalents $ 166,438 $ — $ — $ 166,438 Term deposits $ — $ 40,506 $ — $ 40,506 Asset backed securities — 31,667 — 31,667 Government debt securities — 385,827 — 385,827 Corporate debt securities — 422,662 — 422,662 Available-for-sale investments — 880,662 — 880,662 Total fair value of assets $ 166,438 $ 880,662 $ — $ 1,047,100 Liabilities measured at fair value Common stock warrant liabilities (Public) $ 14,488 $ — $ — $ 14,488 Common stock warrant liabilities (Private Placement) — 9,687 — 9,687 Earnout Shares Liability — — 58,499 58,499 Total fair value of liabilities $ 14,488 $ 9,687 $ 58,499 $ 82,674 December 31, 2021 Level 1 Level 2 Level 3 Total Assets measured at fair value Money market funds $ 929,842 $ — $ — $ 929,842 Cash equivalents $ 929,842 $ — $ — $ 929,842 Term deposits $ — $ 40,069 $ — $ 40,069 Asset backed securities — 69,496 — 69,496 Government debt securities — 47,308 — 47,308 Corporate debt securities — 186,376 — 186,376 Available-for-sale investments — 343,249 — 343,249 Total fair value of assets $ 929,842 $ 343,249 $ — $ 1,273,091 Liabilities measured at fair value Common stock warrant liabilities (Public) $ 26,910 $ — $ — $ 26,910 Common stock warrant liabilities (Private Placement) — 17,992 — 17,992 Earnout Shares Liability — — 109,844 109,844 Total fair value of liabilities $ 26,910 $ 17,992 $ 109,844 $ 154,746 The following is a summary of the Company’s available-for-sale securities (in thousands): September 30, 2022 Adjusted Unrealized Unrealized Losses Recorded Assets measured at fair value Term deposits $ 40,506 $ — $ — $ 40,506 Asset backed securities 32,052 — (385) 31,667 Government debt securities 390,761 — (4,934) 385,827 Corporate debt securities 426,882 — (4,220) 422,662 Total $ 890,201 $ — $ (9,539) $ 880,662 December 31, 2021 Adjusted Unrealized Unrealized Losses Recorded Assets measured at fair value Term deposits $ 40,069 $ — $ — $ 40,069 Asset backed securities 69,579 — (83) 69,496 Government debt securities 47,355 — (47) 47,308 Corporate debt securities 186,471 — (95) 186,376 Total $ 343,474 $ — $ (225) $ 343,249 There were no transfers between Level 1, Level 2 or Level 3 financial instruments in the nine months ended September 30, 2022 and 2021. The following table sets forth a summary of the change in the fair value, which is recognized as a component of other income within the condensed consolidated statement of operations, of the Company’s Level 3 financial liabilities (in thousands): Earnout Shares Liability Fair value as of January 1, 2022 $ 109,844 Change in fair value (51,345) Fair value as of September 30, 2022 $ 58,499

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions	Acquisitions 2021 Acquisitions On January 11, 2021, the Company entered into certain agreements with Uber Technologies, Inc. (“Uber”), under which it acquired Uber Elevate, Inc. (“Uber Elevate”), a portion of Uber’s business dedicated to development of aerial ridesharing. In connection with the acquisition, the Company issued Uber a Convertible Promissory Note (“Uber CPN”) and entered into a collaboration agreement (the “Uber Agreement”). The purchase price allocation for Uber Elevate is as follows (in thousands): Automation platform software technology $ 7,200 Multimodal software technology 4,900 Simulation software technology 4,600 Total acquired finite-lived intangible assets 16,700 Goodwill 10,757 Property and equipment 630 Deferred tax asset 6,129 Total purchase consideration $ 34,216 On April 6, 2021, the Company completed the acquisition of an entity engaged in the development of transportation technology with application in the aviation sector, whereby it acquired all the outstanding shares of the entity in exchange for a purchase consideration of $5.0 million in cash. The acquisition was accounted for as an asset acquisition because substantially all of the fair value of the gross assets acquired was represented by a group of similar assets. The purchase consideration was allocated to $5.0 million of the acquired in-process research and development (“IPR&D”) assets, $0.1 million of the acquired current liabilities and $0.1 million of acquired current assets. In relation to the acquisition, the Company issued 2,677,200 restricted shares of Legacy Joby Series C Preferred Stock with the aggregate acquisition date value of $23.9 million. The Series C Preferred Stock was converted into an equivalent number of shares of Legacy Joby common stock on a one-to-one basis immediately prior to the closing of the Merger, and then into the restricted shares of the Company’s common stock at the time of the Merger. The restricted shares vest contingent upon each employee’s continued employment with the Company or its subsidiaries, and are recognized as stock-based compensation expense over the restricted shares vesting terms. On December 21, 2021, the Company completed the acquisition of an entity engaged in the development of radar systems technology with application in the aviation and other sectors, whereby it acquired all the outstanding shares of the entity in exchange for a total consideration consisting of (i) $2.8 million in cash, and (ii) 340,000 restricted stock units representing the right to receive an equivalent number of shares of the Company’s common stock upon vesting ("RSUs") with the aggregate acquisition date value of $2.4 million. The acquisition was accounted for as a business combination as the assets acquired and liabilities assumed constituted a business in accordance with ASC 805 Business Combinations . The purchase consideration of $2.8 million was allocated to $1.7 million of the acquired intangible assets, primarily developed technology, $1.2 million of the acquired current assets, primarily cash and account receivables, and $0.1 million of the acquired current liabilities. 2022 Acquisitions On March 9, 2022, the Company completed the acquisition of an aerospace composite manufacturing company, whereby it acquired all the purchased assets and assumed selected liabilities in exchange for a total consideration consisting of (i) $1.5 million in cash, and (ii) RSUs with the aggregate acquisition date value of $0.1 million. The acquisition was accounted for as a business combination as the assets acquired and liabilities assumed constituted a business in accordance with ASC 805 Business Combinations . The purchase consideration of $1.5 million was allocated to the following: a $1.1 million in favorable lease assets, $0.4 million of acquired machinery and equipment, $0.1 million of acquired current assets, and $0.1 million of acquired current liabilities. On May 17, 2022, the Company completed the acquisition of an aerospace software engineering company that specializes in full-lifecycle software and firmware development and verification to aviation regulatory standards, in exchange for total cash consideration of $7.2 million. The acquisition was accounted for as a business combination as the assets acquired and liabilities assumed constituted a business in accordance with ASC 805 Business Combinations . Part of the cash consideration in an amount of $2.2 million was temporarily retained by the Company to satisfy the Company’s post-closing indemnification claims, if any, against the seller. This retained amount is payable to the seller, net of indemnification claims, at the one-year anniversary of the acquisition. As of September 30, 2022, this retained amount of $2.2 million is presented as restricted cash on the Company’s condensed consolidated balance sheet, with a related corresponding amount in accrued and other liabilities, reflecting obligations to the seller. In relation to the acquisition, the Company issued 790,592 RSUs with an aggregate acquisition date value of approximately $4.5 million. The Company also paid $0.5 million to the employees of the acquired company, and settled accounts payable to the acquired company of $0.2 million. The RSUs vest contingent upon each employee’s continued employment with the Company or its subsidiaries, and are recognized as stock-based compensation expense over the RSUs’ vesting terms, commencing on the acquisition date. The purchase consideration of $7.2 million was, preliminarily, allocated to $2.9 million of goodwill, primarily resulting from the combined workforce and expected increased regulatory efficiencies, $2.7 million of total intangible assets comprising of $2.6 million of acquired customer relationships intangible asset and $0.1 million of acquired developed technology intangible asset, $1.7 million of acquired current assets, primarily consisting of cash and accounts receivable, $0.3 million of acquired fixed assets, and $0.4 million of acquired current liabilities. Amounts recognized as of the acquisition date are provisional and subject to change within the measurement period as the Company’s fair value assessments are finalized. In September 2022, the Company made certain measurement period adjustments, which included a working capital adjustment with the seller in accordance with the agreement terms, resulting in an increase to the purchase consideration of $0.1 million which will be paid during the three months ended December 31, 2022.

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	Balance Sheet Components Property and Equipment, Net Property and equipment, net consists of the following (in thousands): September 30, December 31, Equipment $ 58,613 $ 45,501 Computer software 10,088 8,410 Leasehold improvements 11,650 9,364 Molds and tooling 9,818 8,052 Vehicles and aircraft 1,582 1,198 Buildings 4,504 — Furniture and fixtures 376 319 Construction in-progress 4,599 6,394 Gross property and equipment 101,230 79,238 Accumulated depreciation and amortization (38,276) (26,083) Property and equipment, net $ 62,954 $ 53,155 Depreciation and amortization expense of property and equipment for the three and nine months ended September 30, 2022 was $4.8 million and $13.4 million, respectively and $3.2 million and $8.6 million for the three and nine months ended September 30, 2021, respectively. Vehicles and aircraft includes utility automobiles used at the Company’s various facilities and purchased aircraft to support the Company’s air operations and training. Intangible Assets, Net The intangible assets consist of the following (in thousands): September 30, December 31, Automation platform software $ 7,200 $ 7,200 Multimodal software technology 4,900 4,900 System simulation software technology 4,600 4,600 Other intangibles 5,328 1,655 Gross intangible assets 22,028 18,355 Accumulated amortization (7,830) (3,843) Intangible assets, net $ 14,198 $ 14,512 Amortization expense related to intangible assets for the three and nine months ended September 30, 2022 was $1.5 million and $4.0 million, respectively and $1.0 million and $2.9 million for the three and nine months ended September 30, 2021, respectively. As of September 30, 2022 the weighted-average amortization period of intangible assets was 2.53 years. The following table presents the estimated future amortization expense of acquired amortizable intangible assets as of September 30, 2022 (in thousands): Fiscal Year Amount 2022 (remainder) $ 1,535 2023 6,107 2024 4,370 2025 2,186 $ 14,198 Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consist of the following (in thousands): September 30, December 31, Prepaid equipment $ 5,211 $ 2,923 Prepaid software 3,042 4,494 Prepaid taxes 2,142 1,332 Prepaid insurance 8,479 8,031 Other 1,360 636 Total $ 20,234 $ 17,416 Other non-current assets Other non-current assets consist of the following (in thousands): September 30, December 31, Contractual agreement asset $ 59,611 $ 59,611 Long term prepaid insurance 5,181 10,511 Other non-current assets 570 199 Total $ 65,362 $ 70,321 Accrued and other current liabilities Accrued and other current liabilities consist of the following (in thousands): September 30, December 31, 2022 Bonus Plan accrual (Note 9) $ 9,274 $ — Vendor related accruals 6,551 4,220 Payroll accruals 2,495 4,026 Acquisition-related obligation accrual 2,167 — Other accruals and current liabilities 4,013 1,965 Total $ 24,500 $ 10,211

Leases

Leases	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Leases	Leases Operating Leases The Company leases various office and research and development facilities under operating lease agreements that expire at various dates through October 2050. Under the terms of the agreements, the Company is responsible for certain insurance, property taxes and maintenance expenses. The Company recognizes rent expense on a straight-line basis over the term of the operating leases. Any difference between cash payments required and rent expense is recorded as deferred rent. Rent expense for the three and nine months ended September 30, 2022 was $1.5 million and $4.3 million, respectively and $1.5 million and $4.1 million for the three and nine months ended September 30, 2021, respectively. Aggregate future minimum lease payments required under the operating leases at September 30, 2022 are as follows (in thousands): As of September 30, 2022 Amount 2022 (remaining three months) $ 1,550 2023 4,925 2024 4,000 2025 1,020 2026 729 2027 and thereafter 3,174 Total minimum future lease payments, operating leases $ 15,398 Capital Leases The Company purchased equipment with total gross book value of $4.5 million under capital lease agreements, of which nil and $0.9 million was purchased during the nine months ended September 30, 2022 and during the year ended December 31, 2021, respectively. Interest rates for the capital leases have ranged from 3.95% to 15.0% per annum. Accumulated depreciation for equipment acquired under the capital leases was $1.5 million and $1.1 million as of September 30, 2022 and December 31, 2021, respectively. Aggregate future minimum principal lease payments under the capital leases at September 30, 2022 are as follows (in thousands): As of September 30, 2022 Amount 2022 (remaining three months) $ 198 2023 294 2024 231 2025 159 2026 150 2027 and thereafter 50 Total payments 1,082 Less current portion (426) Noncurrent portion $ 656

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Contingencies The Company is subject to claims and assessments from time to time in the ordinary course of business. Accruals for litigation and contingencies are reflected in the condensed consolidated financial statements based on management’s assessment, including the advice of legal counsel, of the expected outcome of litigation or other dispute resolution proceedings and/or the expected resolution of contingencies. Liabilities for estimated losses are accrued if the potential losses from any claims or legal proceedings are considered probable and the amounts can be reasonably estimated. Significant judgment is required in both the determination of probability of loss and the determination as to whether the amount can be reasonably estimated. Accruals are based only on information available at the time of the assessment due to the uncertain nature of such matters. As additional information becomes available, management reassesses potential liabilities related to pending claims and litigation and may revise its previous estimates, which could materially affect the Company’s condensed consolidated results of operations in a given period. As of September 30, 2022, and December 31, 2021, the Company was not involved in any material legal proceedings. Indemnifications In the normal course of business, the Company enters into contracts and agreements that contain a variety of representations and warranties and provide for general indemnifications. The Company’s exposure under these agreements is unknown because it involves claims that may be made against the Company in the future, but that have not yet been made. To date, the Company has not paid any claims or been required to defend any action related to its indemnification obligations. However, the Company may record charges in the future as a result of these indemnification obligations.

Stock Warrants and Earnout Shar

Stock Warrants and Earnout Shares	9 Months Ended
	Sep. 30, 2022
Warrants and Rights Note Disclosure [Abstract]
Stock Warrants and Earnout Shares	Stock Warrants and Earnout Shares Private Placement and Public Warrants In connection with the Merger, each of the 17,250,000 publicly-traded warrants (“Public Warrants”) and 11,533,333 private placement warrants (“Private Placement Warrants” and, together with the Public Warrants, the “Common Stock Warrants”) issued to Reinvent Sponsor, LLC (the “Sponsor”) in connection with RTP’s initial public offering and subsequent overallotment were converted into an equal number of warrants that entitle the holder to purchase one share of the Company’s Common stock, par value $0.0001 (“Common Stock”) at an exercise price of $11.50 per share, subject to adjustments, and will expire five years after the completion of the Merger or earlier upon redemption or the Company’s liquidation. Once the Common Stock Warrants become exercisable, the Company may redeem the outstanding Common Stock Warrants subject to certain Common Stock price and other conditions as defined in the Warrant Agreement between RTP and Continental Stock Transfer & Trust Company (“Warrant Agreement”) and the Sponsor Agreement by and among the Company, Sponsor and RTP (“Sponsor Agreement”). During the three months ended September 30, 2022, no Common Stock Warrants were exercised. The Private Placement Warrants were initially recognized as a liability on August 10, 2021, at a fair value of $21.9 million. For the three and nine months ended September 30, 2022, the Private Placement Warrant liability was remeasured to fair value as of September 30, 2022, resulting in a gain of $2.8 million and $8.3 million, respectively, which is included within the gain from change in the fair value of warrants and earnout shares in the condensed consolidated statements of operations. The Public Warrants were initially recognized as a liability on August 10, 2021 at a fair value of $32.8 million. For the three and nine months ended September 30, 2022, the public warrant liability was remeasured to fair value based upon the market price as of September 30, 2022, resulting in a gain of $4.2 million and $12.4 million, respectively, classified within the gain from change in the fair value of warrants and earnout shares in the condensed consolidated statements of operations. Earnout Shares Liability In connection with the Reverse Recapitalization and pursuant to the Sponsor Agreement, Sponsor agreed to certain terms of vesting, lock-up and transfer with respect to the 17,130,000 common shares held by it (“Earnout Shares”). The terms of the Sponsor Agreement specify that the Earnout Shares will vest upon achieving certain specified release events. In accordance with ASC 815 Derivatives and Hedging , the Earnout Shares are not indexed to the Common Stock and therefore are accounted for as a liability (“Earnout Shares Liability”) as of the Closing Date and subsequently remeasured at each reporting date with changes in fair value recorded as a component of other income (expense), net in the condensed consolidated statements of operations. Under the vesting schedule, 20% of the Earnout Shares vest in tranches when the volume-weighted average price of the Company’s common stock quoted on the NYSE is greater than $12.00, $18.00, $24.00, $32.00 and $50.00 for any 20 trading days within a period of 30 trading days (each such occurrence a “Triggering Event”). After ten years following the consummation of the Merger (the “Earnout Period”), any Earnout Shares which have not yet vested are forfeited. No Earnout Shares vested as of September 30, 2022. Earnout Shares Liability at the closing of the Merger on August 10, 2021, was $149.9 million based on a Monte Carlo simulation valuation model using a distribution of potential outcomes on a monthly basis over the Earnout Period using the most reliable information available. During the three and nine months ended September 30, 2022, the Company recognized a gain related to the change in the fair value of the Earnout Shares Liability of $5.5 million and $51.3 million, respectively, included within the gain from change in fair value of warrants and earnout shares in the condensed consolidated statement of operations. Assumptions used in the valuation are as follows: September 30, 2022 December 31, 2021 Expected volatility 70.40 % 72.10 % Risk-free interest rate 3.88 % 1.51 % Dividend rate 0.00 % 0.00 % Expected term (years) 8.86 9.61

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation 2016 and 2021 Stock Plans In November 2016, the Company’s Board of Directors adopted the 2016 Stock Option and Grant Plan (“2016 Plan”) under which officers, employees, directors, consultants and other key persons of the Company or its affiliates may be granted incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock and restricted stock units. On August 10, 2021, the Company’s Board of Directors amended the 2016 Plan to provide that no new awards could be granted under the 2016 Plan. On August 10, 2021, the Company adopted the 2021 Equity Incentive Plan (“2021 Plan”). Under the 2021 Plan, the Company can grant incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock, restricted stock units and performance awards to employees, directors and consultants. The number of shares available for issuance under the 2021 Plan will be increased on the first day of each fiscal year, beginning on January 1, 2022, in an amount equal to the lesser of (i) a number of shares equal to four percent (4%) of the total number of shares of all classes of common stock of the Company outstanding on the last day of the immediately preceding fiscal year, or (ii) such number of shares determined by the Company’s Board of Directors. On January 1, 2022, the number of shares available for issuance under 2021 plan increased by 24,167,201 shares. On August 10, 2021, the Company adopted the 2021 Employee Stock Purchase Plan (“2021 ESPP”). Under the 2021 ESPP, participating employees may be offered the option to purchase shares of the Company’s Common Stock at a purchase price which equals 85% of the fair market value of the Company’s common stock on the enrollment date or on the exercise date, whichever is lower. The number of shares of common stock available for issuance under the 2021 ESPP will be increased on the first day of each fiscal year beginning on January 1, 2022, in an amount equal to the lesser of (i) a number of shares of common stock equal to half percent (0.5%) of the total number of shares of all classes of common stock of the Company on the last day of the immediately preceding fiscal year, or (ii) such number of shares determined by the Company’s Board of Directors. On January 1, 2022, the number of shares available for issuance under 2021 ESPP increased by 3,020,900 shares. As of September 30, 2022, the Company has not yet implemented the 2021 ESPP and no shares have been issued under the 2021 ESPP. Restricted Stock Units The summary of RSU activity is as follows (in thousands, except per share data): Number of Units Weighted-Average Grant Date Fair Value Per Share Aggregate Intrinsic Value (in thousands) Balances—December 31, 2021 10,032,871 $ 8.60 $ 73,240 Granted 17,818,829 $ 5.57 Vested (3,520,956) $ 7.68 Forfeited (1,129,478) $ 6.83 Balances—September 30, 2022 23,201,266 $ 6.49 $ 100,461 On December 16, 2021, the Company’s Board of Directors approved a performance-based bonus program under which RSUs will be awarded in connection with the achievement of specified goals to be achieved in 2022 ("2022 Bonus Plan"). The RSU awards will be granted when the achievement of each goal is approved by the Company’s Board of Directors or Compensation Committee, and the RSUs will vest on January 1, 2023 provided the employee or consultant continues to be a service provider on that date. The target bonus opportunity is equal to 30% of the employee’s base salary as of the applicable grant date unless otherwise established by the Company’s Compensation Committee, with stretch bonus goals that are one-third higher than the target amounts. The Company recorded stock-based compensation expense of $0.3 million and $15.1 million during the three and nine months ended September 30, 2022, respectively, in relation to 2022 Bonus Plan. The Company will consider the probability of achieving of each of the performance goals at the end of each reporting period and will recognize expense over the requisite period when achievement of the goal is determined to be probable, and will adjust the expense if the probability of achieving the goal later changes. In accordance with ASC 718 Compensation - Stock Compensation , awards under 2022 Bonus Plan are classified as a liability until such time that the respective milestones have been met, at which point the liability is reclassified to equity. If it is determined that the milestone cannot be met, the liability will be reversed. Shares subject to repurchase The Company allows certain option holders to exercise unvested options to purchase shares of common stock. Common shares received from such early exercises are subject to a right of repurchase at the original issuance price. The Company’s repurchase right with respect to these shares lapses as the shares vest. These awards are typically subject to a vesting period of six years. As of September 30, 2022 and December 31, 2021, 4,675,479 and 6,918,483 shares, respectively, were subject to repurchase at a weighted average price of $0.10 per share and $0.10 per share, respectively, and $0.5 million and $0.7 million, respectively, was recorded within the stock repurchase liability in early exercised stock option liabilities on the Company’s condensed consolidated balance sheets. In addition, upon completion of the Reverse Recapitalization 2,677,200 Series C Preferred shares which were subject to time-based vesting conditions were converted to restricted common shares. As of September 30, 2022, the number of such shares that were subject to repurchase was 2,120,011. Stock-based Compensation Expense The following sets forth the total stock-based compensation expense for the Company’s stock options included in the Company’s condensed consolidated statements of operations (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Research and development expenses $ 9,409 $ 6,103 $ 37,519 $ 14,041 Selling, general and administrative expenses 3,634 1,516 14,386 5,377 Total stock-based compensation expense $ 13,043 $ 7,619 $ 51,905 $ 19,418

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions The Company’s Chief Executive Officer and founder has ownership interests in certain vendors providing services to the Company. The services purchased from these vendors include rent of office space and certain utilities and maintenance services related to the property on which the rented premises are located. Expenses and related payments to these vendors totaled $0.2 million and $0.6 million during the three and nine months ended September 30, 2022, respectively and $0.3 million and $1.0 million during the three and nine months ended September 30, 2021, respectively. The Company owed these vendors $0.1 million and $0.1 million as of September 30, 2022 and December 31, 2021, respectively. In addition, the Company entered into certain transactions with SummerBio. These transactions included purchases of COVID-19 testing services for the Company’s employees and certain assets for a total amount of $0.2 million and $1.3 million during the three and nine months ended September 30, 2022, respectively and $0.4 million and $0.9 million during the three and nine months ended September 30, 2021, respectively. Total amount due to SummerBio was nil and $0.1 million at September 30, 2022 and December 31, 2021, respectively.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Net Loss per Share Attributable to Common Stockholders	Net Loss per Share Attributable to Common Stockholders Basic net loss per share is computed by dividing the net loss by the weighted-average number of common shares outstanding for the period. Because the Company reported a net loss for the three and nine months ended September 30, 2022 and 2021, the number of shares used to calculate diluted net loss per common share is the same as the number of shares used to calculate basic net loss per common share for those periods presented because the potentially dilutive shares would have been antidilutive if included in the calculation. The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Numerator: Net loss attributable to common stockholders $ (79,206) $ (78,858) $ (191,099) $ (185,369) Denominator: Weighted-average shares outstanding 583,970,409 385,560,732 581,458,391 203,536,351 Net loss per share attributable to common stockholders, basic and diluted $ (0.14) $ (0.20) $ (0.33) $ (0.91) The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive: September 30, 2022 September 30, 2021 Common stock warrants 28,783,333 28,783,333 Unvested restricted stock units 23,201,266 10,154,074 Options to purchase common stock and unvested restricted stock awards 25,145,381 22,384,350 Earnout Shares 17,130,000 17,130,000 Total 94,259,980 78,451,757

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date financial statements were issued. On October 7, 2022, the Company entered into a collaboration agreement with Delta Air Lines (“Delta”) in which the parties agreed to develop a long-term strategic relationship for a premium airport transportation service that the Company plans to offer to Delta passengers. In connection with this agreement, the Company sold and issued to Delta 11,044,232 shares of the Company’s Common Stock at a purchase price of $5.4327 per share, for an aggregate purchase price of $60 million. In addition, the Company entered into a warrant agreement which entitles Delta to purchase 12,833,333 shares of the Company’s Common Stock in two tranches, exercisable after the satisfaction of certain collaboration milestones and subject to customary adjustments as defined in the warrant agreement.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The condensed consolidated financial statements are unaudited and have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include all adjustments necessary for the fair presentation of the Company’s financial position as of September 30, 2022 and December 31, 2021 and results of operations for the three and nine months ended September 30, 2022 and 2021 and cash flows for the nine months ended September 30, 2022. The condensed consolidated financial statements include accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments with remaining original maturity of three months or less, from the date of purchase, to be cash and cash equivalents. The recorded carrying amount of cash and cash equivalents approximates their fair value.
Investment in SummerBio, LLC	Investment in SummerBio, LLC Following the outbreak of the COVID-19 pandemic, the Company’s management determined that certain previously developed technology that was accessible to the Company could be repurposed and applied in providing high-volume rapid COVID-19 testing through its investment in SummerBio, LLC (“SummerBio”), a related party. The Company has determined that it is not the primary beneficiary of SummerBio. Therefore, it accounts for its investment in SummerBio under the equity method of accounting
Recently Adopted Accounting Pronouncements and New Accounting Pronouncements Not Yet Adopted	Recently Adopted Accounting Pronouncements In January 2020, the FASB issued ASU 2020-01, Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815): Clarifying the Interactions Between Topic 321, Topic 323, and Topic 815 - a consensus of the FASB Emerging Issues Task Force , which makes improvements related to the following two topics: (1) accounting for certain equity securities when the equity method of accounting is applied or discontinued, and (2) scope considerations related to forward contracts and purchased options on certain securities. The Company adopted this pronouncement in the first quarter of 2022 and the impact of the provisions of this standard on its Condensed Consolidated Financial Statements was immaterial. New Accounting Pronouncements Not Yet Adopted The Company is an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012. As such the Company is eligible for exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies, including reduced reporting and extended transition periods to comply with new or revised accounting standards for public business entities. The Company has elected to avail itself of this exemption and, therefore, will not be subject to the timeline for adopting new or revised accounting standards for public business entities that are not emerging growth companies, and will follow the transition guidance applicable to private companies. In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) . In July 2018, the FASB issued ASU No. 2018-10, Codification Improvements to Topic 842, Leases , which provides clarification to ASU No. 2016-02. These ASUs require an entity to recognize a lease liability and a right-of-use (“ROU”) asset in the balance sheets for leases with lease terms of more than 12 months. Lessor accounting is largely unchanged, while lessees will no longer be provided with a source of off-balance-sheet financing. This guidance is effective for fiscal years beginning after December 15, 2021, and for interim periods within fiscal years beginning after December 15, 2022. In July 2018, the FASB issued ASU No. 2018-11, Leases (Topic 842): Targeted Improvements , which allows entities to elect a modified retrospective transition method where entities may continue to apply the existing lease guidance during the comparative periods and apply the new lease requirements through a cumulative effect adjustment in the period of adoptions rather than in the earliest period presented. The Company is currently evaluating, but has not yet completed, the assessment of the quantitative impact that adopting these ASUs will have on its consolidated financial statements and assessing any changes to its processes and controls. The Company currently estimates an ROU asset and lease liability of approximately $20 million to $30 million. These values are preliminary as the Company finalizes its review of lease agreements, incremental borrowing rates, and continues to evaluate material contracts for additional embedded lease agreements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which amends the impairment model by requiring entities to use a forward-looking approach based on expected losses to estimate credit losses on certain types of financial instruments, including trade receivables and available-for-sale debt securities. The guidance is effective for the Company beginning in the first quarter of 2023. The Company is evaluating the impact of adopting this guidance on its consolidated financial statements. In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes , that simplifies the accounting for income taxes by eliminating certain exceptions related to the approach for intra-period tax allocation and modified the methodology for calculating income taxes in an interim period. It also clarifies and simplifies other aspects of the accounting for income taxes. The guidance is effective for the Company for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022 with early adoption permitted. The Company is evaluating the effect of this guidance on its consolidated financial statements. In June 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting
Fair Value Measurements	A financial instrument’s categorization within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires management to make judgments and consider factors specific to the asset or liability. The Company’s financial assets consist of Level 1 and 2 assets. The Company classifies its cash equivalents and marketable debt securities within Level 1 or Level 2 because they are valued using either quoted market prices or inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. The Company’s fixed income available-for-sale securities consist of high quality, investment grade securities from diverse issuers. The valuation techniques used to measure the fair value of the Company’s marketable debt securities were derived from non-binding market consensus prices that are corroborated by observable market data and quoted market prices for similar instruments. The Company’s financial liabilities measured at fair value on a recurring basis consist of Level 1, Level 2 and Level 3 liabilities. The Company’s Public Warrants (as defined in Note 8) are classified as Level 1 because they are directly observable in the market. The Company classifies the Private Placement Warrants (as defined in Note 8) within Level 2, because they were valued using inputs other than quoted prices which are directly observable in the market, including readily available pricing for the Company’s Public Warrants. The Company classifies the Earnout Shares Liability (as

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following tables set forth the fair value of the Company’s financial assets and liabilities measured on a recurring basis by level within the fair value hierarchy as of September 30, 2022 and December 31, 2021 (in thousands): September 30, 2022 Level 1 Level 2 Level 3 Total Assets measured at fair value Money market funds $ 166,438 $ — $ — $ 166,438 Cash equivalents $ 166,438 $ — $ — $ 166,438 Term deposits $ — $ 40,506 $ — $ 40,506 Asset backed securities — 31,667 — 31,667 Government debt securities — 385,827 — 385,827 Corporate debt securities — 422,662 — 422,662 Available-for-sale investments — 880,662 — 880,662 Total fair value of assets $ 166,438 $ 880,662 $ — $ 1,047,100 Liabilities measured at fair value Common stock warrant liabilities (Public) $ 14,488 $ — $ — $ 14,488 Common stock warrant liabilities (Private Placement) — 9,687 — 9,687 Earnout Shares Liability — — 58,499 58,499 Total fair value of liabilities $ 14,488 $ 9,687 $ 58,499 $ 82,674 December 31, 2021 Level 1 Level 2 Level 3 Total Assets measured at fair value Money market funds $ 929,842 $ — $ — $ 929,842 Cash equivalents $ 929,842 $ — $ — $ 929,842 Term deposits $ — $ 40,069 $ — $ 40,069 Asset backed securities — 69,496 — 69,496 Government debt securities — 47,308 — 47,308 Corporate debt securities — 186,376 — 186,376 Available-for-sale investments — 343,249 — 343,249 Total fair value of assets $ 929,842 $ 343,249 $ — $ 1,273,091 Liabilities measured at fair value Common stock warrant liabilities (Public) $ 26,910 $ — $ — $ 26,910 Common stock warrant liabilities (Private Placement) — 17,992 — 17,992 Earnout Shares Liability — — 109,844 109,844 Total fair value of liabilities $ 26,910 $ 17,992 $ 109,844 $ 154,746
Summary of Debt Securities, Available-for-sale	The following is a summary of the Company’s available-for-sale securities (in thousands): September 30, 2022 Adjusted Unrealized Unrealized Losses Recorded Assets measured at fair value Term deposits $ 40,506 $ — $ — $ 40,506 Asset backed securities 32,052 — (385) 31,667 Government debt securities 390,761 — (4,934) 385,827 Corporate debt securities 426,882 — (4,220) 422,662 Total $ 890,201 $ — $ (9,539) $ 880,662 December 31, 2021 Adjusted Unrealized Unrealized Losses Recorded Assets measured at fair value Term deposits $ 40,069 $ — $ — $ 40,069 Asset backed securities 69,579 — (83) 69,496 Government debt securities 47,355 — (47) 47,308 Corporate debt securities 186,471 — (95) 186,376 Total $ 343,474 $ — $ (225) $ 343,249
Summary of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following table sets forth a summary of the change in the fair value, which is recognized as a component of other income within the condensed consolidated statement of operations, of the Company’s Level 3 financial liabilities (in thousands): Earnout Shares Liability Fair value as of January 1, 2022 $ 109,844 Change in fair value (51,345) Fair value as of September 30, 2022 $ 58,499

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Recognized Identified Assets Assumed In Business Combination	The purchase price allocation for Uber Elevate is as follows (in thousands): Automation platform software technology $ 7,200 Multimodal software technology 4,900 Simulation software technology 4,600 Total acquired finite-lived intangible assets 16,700 Goodwill 10,757 Property and equipment 630 Deferred tax asset 6,129 Total purchase consideration $ 34,216

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Property, Plant and Equipment	Property and equipment, net consists of the following (in thousands): September 30, December 31, Equipment $ 58,613 $ 45,501 Computer software 10,088 8,410 Leasehold improvements 11,650 9,364 Molds and tooling 9,818 8,052 Vehicles and aircraft 1,582 1,198 Buildings 4,504 — Furniture and fixtures 376 319 Construction in-progress 4,599 6,394 Gross property and equipment 101,230 79,238 Accumulated depreciation and amortization (38,276) (26,083) Property and equipment, net $ 62,954 $ 53,155
Schedule of Intangible Assets	The intangible assets consist of the following (in thousands): September 30, December 31, Automation platform software $ 7,200 $ 7,200 Multimodal software technology 4,900 4,900 System simulation software technology 4,600 4,600 Other intangibles 5,328 1,655 Gross intangible assets 22,028 18,355 Accumulated amortization (7,830) (3,843) Intangible assets, net $ 14,198 $ 14,512
Schedule of Estimated Future Amortization Expense of Acquired Intangible Assets	The following table presents the estimated future amortization expense of acquired amortizable intangible assets as of September 30, 2022 (in thousands): Fiscal Year Amount 2022 (remainder) $ 1,535 2023 6,107 2024 4,370 2025 2,186 $ 14,198
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consist of the following (in thousands): September 30, December 31, Prepaid equipment $ 5,211 $ 2,923 Prepaid software 3,042 4,494 Prepaid taxes 2,142 1,332 Prepaid insurance 8,479 8,031 Other 1,360 636 Total $ 20,234 $ 17,416
Schedule of Other Noncurrent Assets	Other non-current assets consist of the following (in thousands): September 30, December 31, Contractual agreement asset $ 59,611 $ 59,611 Long term prepaid insurance 5,181 10,511 Other non-current assets 570 199 Total $ 65,362 $ 70,321
Schedule of Accrued and Other Liabilities	Accrued and other current liabilities consist of the following (in thousands): September 30, December 31, 2022 Bonus Plan accrual (Note 9) $ 9,274 $ — Vendor related accruals 6,551 4,220 Payroll accruals 2,495 4,026 Acquisition-related obligation accrual 2,167 — Other accruals and current liabilities 4,013 1,965 Total $ 24,500 $ 10,211

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2022
Leases [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases	Aggregate future minimum lease payments required under the operating leases at September 30, 2022 are as follows (in thousands): As of September 30, 2022 Amount 2022 (remaining three months) $ 1,550 2023 4,925 2024 4,000 2025 1,020 2026 729 2027 and thereafter 3,174 Total minimum future lease payments, operating leases $ 15,398
Schedule of Future Minimum Lease Payments for Capital Leases	Aggregate future minimum principal lease payments under the capital leases at September 30, 2022 are as follows (in thousands): As of September 30, 2022 Amount 2022 (remaining three months) $ 198 2023 294 2024 231 2025 159 2026 150 2027 and thereafter 50 Total payments 1,082 Less current portion (426) Noncurrent portion $ 656

Stock Warrants and Earnout Sh_2

Stock Warrants and Earnout Shares (Tables)	9 Months Ended
	Sep. 30, 2022
Warrants and Rights Note Disclosure [Abstract]
Schedule of Assumptions Used to Estimate Fair Value of The Total Earnout Shares Liability	Assumptions used in the valuation are as follows: September 30, 2022 December 31, 2021 Expected volatility 70.40 % 72.10 % Risk-free interest rate 3.88 % 1.51 % Dividend rate 0.00 % 0.00 % Expected term (years) 8.86 9.61

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Nonvested Restricted Stock Units Activity	The summary of RSU activity is as follows (in thousands, except per share data): Number of Units Weighted-Average Grant Date Fair Value Per Share Aggregate Intrinsic Value (in thousands) Balances—December 31, 2021 10,032,871 $ 8.60 $ 73,240 Granted 17,818,829 $ 5.57 Vested (3,520,956) $ 7.68 Forfeited (1,129,478) $ 6.83 Balances—September 30, 2022 23,201,266 $ 6.49 $ 100,461
Summary of stock-based compensation expense	The following sets forth the total stock-based compensation expense for the Company’s stock options included in the Company’s condensed consolidated statements of operations (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2022 2021 2022 2021 Research and development expenses $ 9,409 $ 6,103 $ 37,519 $ 14,041 Selling, general and administrative expenses 3,634 1,516 14,386 5,377 Total stock-based compensation expense $ 13,043 $ 7,619 $ 51,905 $ 19,418

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders	The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data): Three Months Ended Nine Months Ended 2022 2021 2022 2021 Numerator: Net loss attributable to common stockholders $ (79,206) $ (78,858) $ (191,099) $ (185,369) Denominator: Weighted-average shares outstanding 583,970,409 385,560,732 581,458,391 203,536,351 Net loss per share attributable to common stockholders, basic and diluted $ (0.14) $ (0.20) $ (0.33) $ (0.91)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following outstanding shares of potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive: September 30, 2022 September 30, 2021 Common stock warrants 28,783,333 28,783,333 Unvested restricted stock units 23,201,266 10,154,074 Options to purchase common stock and unvested restricted stock awards 25,145,381 22,384,350 Earnout Shares 17,130,000 17,130,000 Total 94,259,980 78,451,757

Summary of Significant Accoun_3

Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Jun. 30, 2022	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2022	Dec. 31, 2021
Summary Of Significant Accounting Policies [Line Items]
Restricted cash		$ 3,966,000	$ 762,000	$ 3,966,000	$ 762,000
Income from equity method investment		$ 0	10,331,000	$ 19,039,000	19,222,000
Minimum | Forecast | Cumulative Effect, Period of Adoption, Adjustment
Summary Of Significant Accounting Policies [Line Items]
Right-of-use asset						$ 20,000,000
Lease liability						20,000,000
Maximum | Forecast | Cumulative Effect, Period of Adoption, Adjustment
Summary Of Significant Accounting Policies [Line Items]
Right-of-use asset						30,000,000
Lease liability						$ 30,000,000
SummerBio
Summary Of Significant Accounting Policies [Line Items]
Ownership interest		43.40%		43.40%			43.40%
Impairment from equity method investment	$ 6,800,000
Income from equity method investment		$ 0	$ 10,300,000	$ 19,000,000	$ 19,200,000
Letter of Credit
Summary Of Significant Accounting Policies [Line Items]
Restricted cash		1,000,000		1,000,000
Lease Obligation
Summary Of Significant Accounting Policies [Line Items]
Restricted cash		800,000		800,000			$ 800,000
Acquired Current Liabilities
Summary Of Significant Accounting Policies [Line Items]
Restricted cash		$ 2,200,000		$ 2,200,000

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Assets measured at fair value
Recorded Basis	$ 880,662	$ 343,249
Liabilities measured at fair value
Common stock warrant liabilities	24,175	44,902
Earnout Shares Liability	58,499	109,844
Term deposits
Assets measured at fair value
Recorded Basis	40,506	40,069
Asset backed securities
Assets measured at fair value
Recorded Basis	31,667	69,496
Government debt securities
Assets measured at fair value
Recorded Basis	385,827	47,308
Corporate debt securities
Assets measured at fair value
Recorded Basis	422,662	186,376
Fair Value Measurements Recurring
Assets measured at fair value
Cash equivalents	166,438	929,842
Recorded Basis	880,662	343,249
Total fair value of assets	1,047,100	1,273,091
Liabilities measured at fair value
Earnout Shares Liability	58,499	109,844
Total fair value of liabilities	82,674	154,746
Fair Value Measurements Recurring | Common stock warrant liabilities (Public)
Liabilities measured at fair value
Common stock warrant liabilities	14,488	26,910
Fair Value Measurements Recurring | Common stock warrant liabilities (Private Placement)
Liabilities measured at fair value
Common stock warrant liabilities	9,687	17,992
Fair Value Measurements Recurring | Money market funds
Assets measured at fair value
Cash equivalents	166,438	929,842
Fair Value Measurements Recurring | Term deposits
Assets measured at fair value
Recorded Basis	40,506	40,069
Fair Value Measurements Recurring | Asset backed securities
Assets measured at fair value
Recorded Basis	31,667	69,496
Fair Value Measurements Recurring | Government debt securities
Assets measured at fair value
Recorded Basis	385,827	47,308
Fair Value Measurements Recurring | Corporate debt securities
Assets measured at fair value
Recorded Basis	422,662	186,376
Fair Value Measurements Recurring | Level 1
Assets measured at fair value
Cash equivalents	166,438	929,842
Recorded Basis	0	0
Total fair value of assets	166,438	929,842
Liabilities measured at fair value
Earnout Shares Liability	0	0
Total fair value of liabilities	14,488	26,910
Fair Value Measurements Recurring | Level 1 | Common stock warrant liabilities (Public)
Liabilities measured at fair value
Common stock warrant liabilities	14,488	26,910
Fair Value Measurements Recurring | Level 1 | Common stock warrant liabilities (Private Placement)
Liabilities measured at fair value
Common stock warrant liabilities	0	0
Fair Value Measurements Recurring | Level 1 | Money market funds
Assets measured at fair value
Cash equivalents	166,438	929,842
Fair Value Measurements Recurring | Level 1 | Term deposits
Assets measured at fair value
Recorded Basis	0	0
Fair Value Measurements Recurring | Level 1 | Asset backed securities
Assets measured at fair value
Recorded Basis	0	0
Fair Value Measurements Recurring | Level 1 | Government debt securities
Assets measured at fair value
Recorded Basis	0	0
Fair Value Measurements Recurring | Level 1 | Corporate debt securities
Assets measured at fair value
Recorded Basis	0	0
Fair Value Measurements Recurring | Level 2
Assets measured at fair value
Cash equivalents	0	0
Recorded Basis	880,662	343,249
Total fair value of assets	880,662	343,249
Liabilities measured at fair value
Earnout Shares Liability	0	0
Total fair value of liabilities	9,687	17,992
Fair Value Measurements Recurring | Level 2 | Common stock warrant liabilities (Public)
Liabilities measured at fair value
Common stock warrant liabilities	0	0
Fair Value Measurements Recurring | Level 2 | Common stock warrant liabilities (Private Placement)
Liabilities measured at fair value
Common stock warrant liabilities	9,687	17,992
Fair Value Measurements Recurring | Level 2 | Money market funds
Assets measured at fair value
Cash equivalents	0	0
Fair Value Measurements Recurring | Level 2 | Term deposits
Assets measured at fair value
Recorded Basis	40,506	40,069
Fair Value Measurements Recurring | Level 2 | Asset backed securities
Assets measured at fair value
Recorded Basis	31,667	69,496
Fair Value Measurements Recurring | Level 2 | Government debt securities
Assets measured at fair value
Recorded Basis	385,827	47,308
Fair Value Measurements Recurring | Level 2 | Corporate debt securities
Assets measured at fair value
Recorded Basis	422,662	186,376
Fair Value Measurements Recurring | Level 3
Assets measured at fair value
Cash equivalents	0	0
Recorded Basis	0	0
Total fair value of assets	0	0
Liabilities measured at fair value
Earnout Shares Liability	58,499	109,844
Total fair value of liabilities	58,499	109,844
Fair Value Measurements Recurring | Level 3 | Common stock warrant liabilities (Public)
Liabilities measured at fair value
Common stock warrant liabilities	0	0
Fair Value Measurements Recurring | Level 3 | Common stock warrant liabilities (Private Placement)
Liabilities measured at fair value
Common stock warrant liabilities	0	0
Fair Value Measurements Recurring | Level 3 | Money market funds
Assets measured at fair value
Cash equivalents	0	0
Fair Value Measurements Recurring | Level 3 | Term deposits
Assets measured at fair value
Recorded Basis	0	0
Fair Value Measurements Recurring | Level 3 | Asset backed securities
Assets measured at fair value
Recorded Basis	0	0
Fair Value Measurements Recurring | Level 3 | Government debt securities
Assets measured at fair value
Recorded Basis	0	0
Fair Value Measurements Recurring | Level 3 | Corporate debt securities
Assets measured at fair value
Recorded Basis	$ 0	$ 0

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Debt Securities, Available-for-sale (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Adjusted Basis	$ 890,201	$ 343,474
Unrealized Gains	0	0
Unrealized Losses	(9,539)	(225)
Recorded Basis	880,662	343,249
Term deposits
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Adjusted Basis	40,506	40,069
Unrealized Gains	0	0
Unrealized Losses	0	0
Recorded Basis	40,506	40,069
Asset backed securities
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Adjusted Basis	32,052	69,579
Unrealized Gains	0	0
Unrealized Losses	(385)	(83)
Recorded Basis	31,667	69,496
Government debt securities
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Adjusted Basis	390,761	47,355
Unrealized Gains	0	0
Unrealized Losses	(4,934)	(47)
Recorded Basis	385,827	47,308
Corporate debt securities
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Adjusted Basis	426,882	186,471
Unrealized Gains	0	0
Unrealized Losses	(4,220)	(95)
Recorded Basis	$ 422,662	$ 186,376

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Beginning balance	$ 109,844
Change in fair value	(51,345)
Ending balance	$ 58,499

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Liability [Member]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Line Items]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net	$ 0	$ 0

Acquisitions - Schedule of Reco

Acquisitions - Schedule of Recognized Identified Assets Assumed In Business Combination (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021	Jan. 11, 2021
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Goodwill	$ 14,011	$ 10,757
Uber Elevate
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Finite-lived intangible assets			$ 16,700
Goodwill			10,757
Property and equipment			630
Deferred tax asset			6,129
Total purchase consideration			34,216
Uber Elevate | Automation platform software technology
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Finite-lived intangible assets			7,200
Uber Elevate | Multimodal software technology
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Finite-lived intangible assets			4,900
Uber Elevate | System simulation software technology
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Finite-lived intangible assets			$ 4,600

Acquisitions - Assets Acquisiti

Acquisitions - Assets Acquisitions Narrative (Details) - Transportation Technology Entity $ in Millions	Apr. 06, 2021 USD ($) shares
Asset Acquisition, Consideration Transferred [Abstract]
Asset acquisition, consideration transferred	$ 5
In Process Research and Development
Asset Acquisition, Consideration Transferred [Abstract]
Asset acquisition, consideration transferred	5
Acquired Current Liabilities
Asset Acquisition, Consideration Transferred [Abstract]
Asset acquisition, consideration transferred	0.1
Acquired Current Assets
Asset Acquisition, Consideration Transferred [Abstract]
Asset acquisition, consideration transferred	$ 0.1
Redeemable Convertible Preferred Stock
Business Combination, Separately recognized Transactions, Additional Disclosures [Abstract]
Stock issued during period, shares, restricted stock award, gross | shares	2,677,200
Stock issued during period, value, restricted stock award, gross	$ 23.9
Preferred stock, convertible, conversion ratio	1

Acquisitions - Business Combina

Acquisitions - Business Combinations Narrative (Details) - USD ($) $ in Thousands				1 Months Ended	9 Months Ended
	May 17, 2022	Mar. 09, 2022	Dec. 21, 2021	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Goodwill				$ 14,011	$ 14,011	$ 10,757
Business Combination, Separately recognized Transactions, Additional Disclosures [Abstract]
Restricted cash				3,204	$ 3,204	0
Unvested restricted stock units
Business Combination, Separately recognized Transactions, Additional Disclosures [Abstract]
Awards Granted (in shares)					17,818,829
Aggregate intrinsic value				100,461	$ 100,461	$ 73,240
Radar Systems Technology Entity
Business Acquisition [Line Items]
Cash payments			$ 2,800
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Finite-lived intangible assets			1,700
Acquired current assets			1,200
Acquired current liabilities			100
Total purchase consideration			$ 2,800
Radar Systems Technology Entity | Unvested restricted stock units
Business Combination, Separately recognized Transactions, Additional Disclosures [Abstract]
Awards Granted (in shares)			340,000
Aggregate intrinsic value			$ 2,400
Radar Systems Technology Entity | Developed Technology Rights
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Finite-lived intangible assets			$ 1,700
Aerospace Composites Manufacturing Entity
Business Acquisition [Line Items]
Cash payments		$ 1,500
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Finite-lived intangible assets		1,100
Property and equipment		400
Acquired current assets		100
Acquired current liabilities		100
Total purchase consideration		1,500
Aerospace Composites Manufacturing Entity | Unvested restricted stock units
Business Combination, Separately recognized Transactions, Additional Disclosures [Abstract]
Aggregate intrinsic value		100
Aerospace Composites Manufacturing Entity | Off-Market Favorable Lease
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Finite-lived intangible assets		$ 1,100
Aerospace Software Engineering Entity
Business Acquisition [Line Items]
Cash payments	$ 7,200
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Finite-lived intangible assets	2,700
Goodwill	2,900
Property and equipment	300
Acquired current assets	1,700
Acquired current liabilities	400
Total purchase consideration	7,200
Business Combination, Separately recognized Transactions, Additional Disclosures [Abstract]
Restricted cash	2,200			2,200	$ 2,200
Payment to employees	500
Settlement of accounts payable	$ 200
Increase to purchase consideration				$ 100
Aerospace Software Engineering Entity | Unvested restricted stock units
Business Combination, Separately recognized Transactions, Additional Disclosures [Abstract]
Awards Granted (in shares)	790,592
Aggregate intrinsic value	$ 4,500
Aerospace Software Engineering Entity | Customer Relationships
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Finite-lived intangible assets	2,600
Aerospace Software Engineering Entity | Developed Technology Rights
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]
Finite-lived intangible assets	$ 100

Balance sheet Components - Summ

Balance sheet Components - Summary of Property, Plant and Equipment (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Property Plant And Equipment [Line Items]
Gross property and equipment	$ 101,230	$ 79,238
Accumulated depreciation and amortization	(38,276)	(26,083)
Property and equipment, net	62,954	53,155
Equipment
Property Plant And Equipment [Line Items]
Gross property and equipment	58,613	45,501
Computer software
Property Plant And Equipment [Line Items]
Gross property and equipment	10,088	8,410
Leasehold improvements
Property Plant And Equipment [Line Items]
Gross property and equipment	11,650	9,364
Molds and tooling
Property Plant And Equipment [Line Items]
Gross property and equipment	9,818	8,052
Vehicles and aircraft
Property Plant And Equipment [Line Items]
Gross property and equipment	1,582	1,198
Buildings
Property Plant And Equipment [Line Items]
Gross property and equipment	4,504	0
Furniture and fixtures
Property Plant And Equipment [Line Items]
Gross property and equipment	376	319
Construction in-progress
Property Plant And Equipment [Line Items]
Gross property and equipment	$ 4,599	$ 6,394

Balance sheet Components - Addi

Balance sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Depreciation and amortization expense	$ 4.8	$ 3.2	$ 13.4	$ 8.6
Amortization of Intangible Assets	$ 1.5	$ 1	$ 4	$ 2.9
Weighted-average amortization period of intangible assets			2 years 6 months 10 days

Balance sheet Components - Sche

Balance sheet Components - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Indefinite Lived Intangible Assets By Major Class [Line Items]
Gross intangible assets	$ 22,028	$ 18,355
Accumulated amortization	(7,830)	(3,843)
Intangible assets, net	14,198	14,512
Automation platform software technology
Indefinite Lived Intangible Assets By Major Class [Line Items]
Gross intangible assets	7,200	7,200
Multimodal software technology
Indefinite Lived Intangible Assets By Major Class [Line Items]
Gross intangible assets	4,900	4,900
System simulation software technology
Indefinite Lived Intangible Assets By Major Class [Line Items]
Gross intangible assets	4,600	4,600
Other intangibles
Indefinite Lived Intangible Assets By Major Class [Line Items]
Gross intangible assets	$ 5,328	$ 1,655

Balance sheet Components - Sc_2

Balance sheet Components - Schedule of Estimated Future Amortization Expense of Acquired Intangible Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
2022 (remainder)	$ 1,535
2023	6,107
2024	4,370
2025	2,186
Intangible assets, net	$ 14,198	$ 14,512

Balance sheet Components - Sc_3

Balance sheet Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid equipment	$ 5,211	$ 2,923
Prepaid software	3,042	4,494
Prepaid taxes	2,142	1,332
Prepaid insurance	8,479	8,031
Other	1,360	636
Total	$ 20,234	$ 17,416

Balance sheet Components - Sc_4

Balance sheet Components - Schedule of Other Noncurrent Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Contractual agreement asset	$ 59,611	$ 59,611
Long term prepaid insurance	5,181	10,511
Other non-current assets	570	199
Total	$ 65,362	$ 70,321

Balance sheet Components - Sc_5

Balance sheet Components - Schedule of Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
2022 Bonus Plan accrual (Note 9)	$ 9,274	$ 0
Vendor related accruals	6,551	4,220
Payroll accruals	2,495	4,026
Acquisition-related obligation accrual	2,167	0
Other accruals and current liabilities	4,013	1,965
Total	$ 24,500	$ 10,211

Leases - Additional Information

Leases - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Lessor Lease Description [Line Items]
Operating leases, rent expense	$ 1,500,000	$ 1,500,000	$ 4,300,000	$ 4,100,000
Capital Lease Obligations
Lessor Lease Description [Line Items]
Gross book value under capital lease agreement	4,500,000		4,500,000
Property, Plant and Equipment, Additions			0		$ 900,000
Accumulated depreciation for equipment	$ 1,500,000		$ 1,500,000		$ 1,100,000
Minimum | Capital Lease Obligations
Lessor Lease Description [Line Items]
Long-term debt, percentage bearing fixed interest, percentage rate	3.95%		3.95%
Maximum | Capital Lease Obligations
Lessor Lease Description [Line Items]
Long-term debt, percentage bearing fixed interest, percentage rate	15%		15%

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Rental Payments under Operating Leases (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Leases [Abstract]
2022 (remaining three months)	$ 1,550
2023	4,925
2024	4,000
2025	1,020
2026	729
2027 and thereafter	3,174
Total minimum future lease payments, operating leases	$ 15,398

Leases - Schedule of Future M_2

Leases - Schedule of Future Minimum Rental Payments under Capital Leases (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Leases [Abstract]
2022 (remaining three months)	$ 198
2023	294
2024	231
2025	159
2026	150
2027 and thereafter	50
Total payments	1,082
Less current portion	(426)
Noncurrent portion	$ 656

Stock Warrants and Earnout Sh_3

Stock Warrants and Earnout Shares - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended		9 Months Ended
	Aug. 10, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Class of Warrant or Right [Line Items]
Common stock, par value (in dollars per share)		$ 0.0001		$ 0.0001		$ 0.0001
Warrant liability		$ 24,175		$ 24,175		$ 44,902
Gain (Loss) from change in fair value of warrants and earnout shares		12,560	$ (11,489)	72,072	$ (11,489)
Earnout Shares Liability		58,499		58,499		$ 109,844
Private Placement Warrants
Class of Warrant or Right [Line Items]
Warrants issued to sponsor (in shares)	11,533,333
Warrants and rights outstanding, term	5 years
Warrant liability	$ 21,900
Gain (Loss) from change in fair value of warrants and earnout shares		2,800		8,300
Public Warrants
Class of Warrant or Right [Line Items]
Warrants issued to sponsor (in shares)	17,250,000
Warrants and rights outstanding, term	5 years
Warrant liability	$ 32,800
Gain (Loss) from change in fair value of warrants and earnout shares		4,200		12,400
Earnout Shares
Class of Warrant or Right [Line Items]
Warrants and rights outstanding, term	10 years
Gain (Loss) from change in fair value of warrants and earnout shares		$ 5,500		$ 51,300
Percentage of shares held for sale				20%
Earnout Shares Liability	$ 149,900
Earnout Shares | Minimum
Class of Warrant or Right [Line Items]
Number of trading days				20 days
Earnout Shares | Maximum
Class of Warrant or Right [Line Items]
Number of trading days				30 days
Earnout Shares | Tranche One
Class of Warrant or Right [Line Items]
Weighted average price per share (in dollars per share)		$ 12		$ 12
Earnout Shares | Tranche Two
Class of Warrant or Right [Line Items]
Weighted average price per share (in dollars per share)		18		18
Earnout Shares | Tranche Three
Class of Warrant or Right [Line Items]
Weighted average price per share (in dollars per share)		24		24
Earnout Shares | Tranche Four
Class of Warrant or Right [Line Items]
Weighted average price per share (in dollars per share)		32		32
Earnout Shares | Tranche Five
Class of Warrant or Right [Line Items]
Weighted average price per share (in dollars per share)		50		50
Common Stock
Class of Warrant or Right [Line Items]
Lock-up and transfer of common shares (in shares)	17,130,000
Common Stock | Private Placement Warrants
Class of Warrant or Right [Line Items]
Common stock, par value (in dollars per share)	$ 0.0001
Class of warrants exercise price per share (in dollars per share)		11.50		11.50
Common Stock | Public Warrants
Class of Warrant or Right [Line Items]
Common stock, par value (in dollars per share)	$ 0.0001
Class of warrants exercise price per share (in dollars per share)		$ 11.50		$ 11.50

Stock Warrants and Earnout Sh_4

Stock Warrants and Earnout Shares - Schedule of Assumptions Used to Estimate Fair Value of Earnout Shares Liability (Details)	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Warrants and Rights Note Disclosure [Abstract]
Expected volatility	70.40%	72.10%
Risk-free interest rate	3.88%	1.51%
Dividend rate	0%	0%
Expected term (years)	8 years 10 months 9 days	9 years 7 months 9 days

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands			3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 16, 2021	Aug. 10, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based payment arrangement, expense			$ 13,043	$ 7,619	$ 51,905	$ 19,418
Stock repurchase liability			463		$ 463		$ 711
Employee Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Additional shares authorized (in shares)					3,020,900
Purchase price of common stock expressed as a percentage of its fair value		85%
Share-based compensation arrangement by share-based payment award percentage		a number of shares of common stock equal to half percent (0.5%) of the total number of shares of all classes of common stock of the Company on the last day of the immediately preceding fiscal year
ESPP stock issued during the period (in shares)					0
Performance Shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Target bonus threshold	30%
Increase in target amounts	one-third
Share-based payment arrangement, expense			$ 300		$ 15,100
Other Stock Based Awards | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares subject to vesting conditions					2,120,011
Other Stock Based Awards | Series C Preferred Stock
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Payments for advisory services shares (in shares)					2,677,200
Options to purchase common stock and unvested restricted stock awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares vesting period					6 years
Repurchase price per share (in dollars per share)			$ 0.10		$ 0.10		$ 0.10
Options to purchase common stock and unvested restricted stock awards | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares to be repurchased (in shares)					4,675,479		6,918,483
Stock repurchase liability			$ 500		$ 500		$ 700
2021 Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of share outstanding					4%
Additional shares authorized (in shares)					24,167,201

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Nonvested Restricted Stock Units Activity (Details) - Unvested restricted stock units - USD ($) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Number of Units
Beginning balance (in shares)	10,032,871
Granted (in shares)	17,818,829
Vested (in shares)	(3,520,956)
Forfeited (in shares)	(1,129,478)
Ending balance (in shares)	23,201,266
Weighted-Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share)	$ 8.60
Granted (in dollars per share)	5.57
Vested (in dollars per share)	7.68
Forfeited (in dollars per share)	6.83
Ending balance (in dollars per share)	$ 6.49
Aggregate Intrinsic Value	$ 100,461	$ 73,240

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based payment arrangement, expense	$ 13,043	$ 7,619	$ 51,905	$ 19,418
Research and development expenses
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based payment arrangement, expense	9,409	6,103	37,519	14,041
Selling, general and administrative expenses
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based payment arrangement, expense	$ 3,634	$ 1,516	$ 14,386	$ 5,377

Related Party Transactions - Ad

Related Party Transactions - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
SummerBio
Related Party Transaction [Line Items]
Expenses and related payments	$ 200,000	$ 400,000	$ 1,300,000	$ 900,000
Due to related party	0		0		$ 100,000
Office Space And Certain Utilities And Maintenance Services
Related Party Transaction [Line Items]
Expenses and related payments	200,000	$ 300,000	600,000	$ 1,000,000
Due to related party	$ 100,000		$ 100,000		$ 100,000

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net loss attributable to common stockholders	$ (79,206)	$ (78,858)	$ (191,099)	$ (185,369)
Denominator:
Weighted average number of shares outstanding, basic (in shares)	583,970,409	385,560,732	581,458,391	203,536,351
Weighted average number of shares outstanding, diluted (in shares)	583,970,409	385,560,732	581,458,391	203,536,351
Net loss per share, basic (in dollars per share)	$ (0.14)	$ (0.20)	$ (0.33)	$ (0.91)
Net loss per share, diluted (in dollars per share)	$ (0.14)	$ (0.20)	$ (0.33)	$ (0.91)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	94,259,980	78,451,757
Common stock warrants
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	28,783,333	28,783,333
Unvested restricted stock units
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	23,201,266	10,154,074
Options to purchase common stock and unvested restricted stock awards
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	25,145,381	22,384,350
Earnout Shares
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	17,130,000	17,130,000

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event $ / shares in Units, $ in Millions	Oct. 07, 2022 USD ($) $ / shares shares
Delta Warrants
Subsequent Event [Line Items]
Class of warrant or right outstanding (in shares)	12,833,333
Common Stock
Subsequent Event [Line Items]
Shares sold and issued in connection with agreement (in shares)	11,044,232
Shares issued, price per share (in dollars per share) | $ / shares	$ 5.4327
Shares sold and issued in connection with agreement | $	$ 60